Niger
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 11.61 (8.18 - 16.22) | 2015 | Modelled | WHO |
| 8.61 (14.38 - 16.65) | 2013 | Modelled | Schweitzer et al, 2015 |
| 8.73 (8.43 - 9.03) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 10.06 (9.78 - 10.35) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.47 (10.17 - 10.81) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.58 (10.31 - 10.89) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.7 (10.35 - 11.05) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.94 (10.58 - 11.30) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.36 (10.99 - 11.75) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.84 (11.43 - 12.25) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.24 (11.78 - 12.69) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.43 (11.95 - 12.93) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.64 (12.17 - 13.13) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.06 (12.55 - 13.61) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.57 (12.99 - 14.16) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14 (13.34 - 14.65) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.21 (13.47 - 14.91) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.27 (13.59 - 14.92) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.32 (13.69 - 14.95) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.37 (13.74 - 15.03) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.43 (13.79 - 15.11) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.5 (13.81 - 15.23) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.58 (13.95 - 15.25) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.68 (14.08 - 15.29) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.78 (14.18 - 15.40) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.89 (14.25 - 15.49) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.99 (14.31 - 15.60) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.08 (14.42 - 15.66) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.18 (14.55 - 15.76) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.28 (14.66 - 15.85) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.39 (14.77 - 15.98) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.49 (14.86 - 16.11) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.27 (8.98 - 9.56) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Children under-5 years
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 6.01 (3.77 - 9.44) | 2015 | Modelled | WHO |
| 3.29 (2.77 - 3.72) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 3.55 (3.02 - 4.03) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.68 (3.23 - 4.12) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.8 (3.33 - 4.27) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.95 (3.45 - 4.45) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.05 (3.51 - 4.56) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.07 (3.53 - 4.61) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.08 (3.53 - 4.60) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.09 (3.55 - 4.58) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.1 (3.55 - 4.59) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.13 (3.55 - 4.69) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.9 (4.21 - 5.53) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.69 (5.79 - 7.53) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.82 (7.61 - 9.92) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.62 (9.10 - 12.05) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.41 (9.64 - 13.10) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.45 (9.79 - 13.03) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.47 (9.90 - 12.99) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.47 (9.96 - 13.06) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.48 (9.93 - 13.13) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.49 (9.79 - 13.33) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.54 (10.02 - 13.15) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.63 (10.13 - 13.13) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.75 (10.23 - 13.12) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.86 (10.26 - 13.26) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.94 (10.25 - 13.34) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12 (10.40 - 13.32) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.07 (10.57 - 13.35) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.15 (10.67 - 13.45) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.23 (10.73 - 13.58) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.3 (10.77 - 13.73) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.44 (2.63 - 4.50) | 2020 | Modelled | WHO |
Showing out of
Show more
Number of people living with chronic HBV
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 2,034,140 (1,962,920 - 2,102,530) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 2,103,710 (2,037,550 - 2,166,820) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,196,020 (2,135,370 - 2,254,760) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,201,050 (2,139,930 - 2,270,340) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,143,660 (2,088,660 - 2,203,960) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,088,290 (2,023,070 - 2,158,120) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,056,920 (1,990,950 - 2,124,970) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,058,610 (1,991,400 - 2,129,420) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,066,720 (1,996,040 - 2,140,400) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,057,900 (1,982,330 - 2,134,920) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,012,820 (1,935,350 - 2,093,870) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,968,670 (1,896,870 - 2,045,720) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,956,770 (1,880,540 - 2,037,170) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,953,720 (1,870,330 - 2,041,320) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,938,810 (1,844,910 - 2,029,490) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,894,370 (1,794,180 - 1,987,290) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,831,350 (1,742,980 - 1,916,190) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,771,490 (1,690,330 - 1,851,410) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,714,400 (1,639,060 - 1,792,720) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,659,780 (1,586,680 - 1,737,990) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,607,580 (1,531,340 - 1,691,000) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,558,340 (1,492,030 - 1,631,990) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,512,810 (1,451,060 - 1,578,050) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,469,950 (1,409,420 - 1,531,260) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,429,160 (1,367,000 - 1,487,560) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,390,190 (1,324,930 - 1,447,990) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,352,880 (1,293,380 - 1,406,260) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,317,930 (1,263,520 - 1,367,460) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,285,100 (1,234,370 - 1,334,260) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,254,270 (1,203,170 - 1,304,130) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,225,090 (1,174,840 - 1,275,090) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 7.25 (4.55 - 10.80) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 11.65 (8.20 - 15.95) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.47 (8.03 - 15.70) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.44 (7.99 - 15.78) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.42 (7.94 - 15.83) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.27 (7.76 - 15.60) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.22 (7.71 - 15.45) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.93 (7.39 - 15.19) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.94 (7.37 - 15.26) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.91 (7.28 - 15.24) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.84 (7.27 - 15.14) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.78 (7.23 - 15.16) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.83 (7.33 - 15.12) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.83 (7.39 - 15.17) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.91 (7.51 - 15.24) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.7 (7.20 - 15) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.72 (7.23 - 15.08) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.34 (6.87 - 14.63) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.99 (6.67 - 14.35) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.47 (6.26 - 13.59) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.17 (6.04 - 12.97) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.92 (5.79 - 12.77) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.62 (5.60 - 12.58) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.44 (5.54 - 12.46) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.37 (5.44 - 12.43) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.36 (5.39 - 12.39) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.26 (5.42 - 12.27) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.26 (5.35 - 12.24) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.94 (5.13 - 11.71) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.24 (5.45 - 12.30) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.25 (4.55 - 10.78) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 2,029 | 2016 | Modelled | WHO |
| 935 (658 - 1,279) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 949 (665 - 1,299) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 977 (682 - 1,347) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,007 (700 - 1,396) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,027 (708 - 1,422) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,057 (727 - 1,456) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,144 (763 - 1,598) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,066 (721 - 1,482) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,106 (745 - 1,543) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,178 (790 - 1,646) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,216 (815 - 1,711) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,316 (899 - 1,844) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,268 (858 - 1,770) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,376 (948 - 1,922) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,402 (944 - 1,965) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,463 (971 - 2,068) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,459 (983 - 2,053) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,467 (980 - 2,108) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,446 (956 - 2,076) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,478 (960 - 2,156) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,455 (958 - 2,057) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,471 (955 - 2,106) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,503 (986 - 2,219) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,549 (1,006 - 2,298) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,606 (1,036 - 2,380) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,714 (1,125 - 2,546) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,649 (1,067 - 2,443) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,777 (1,175 - 2,652) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,779 (1,150 - 2,623) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,688 (1,060 - 2,511) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,688 (1,060 - 2,511) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 81 | 2019 | Survey/reported | WHO/UNICEF |
| 81 | 2020 | Survey/reported | WHO/UNICEF |
| 82 | 2021 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 2.82 (2.24 - 3.53) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.83 (2.26 - 3.56) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.83 (2.26 - 3.57) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.82 (2.25 - 3.56) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.82 (2.25 - 3.57) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.83 (2.25 - 3.59) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.85 (2.27 - 3.61) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.87 (2.30 - 3.65) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.9 (2.32 - 3.68) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.92 (2.33 - 3.71) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.95 (2.35 - 3.74) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.97 (2.37 - 3.75) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3 (2.40 - 3.80) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.03 (2.42 - 3.83) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.05 (2.44 - 3.86) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.08 (2.46 - 3.90) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.1 (2.48 - 3.91) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.12 (2.50 - 3.95) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.15 (2.52 - 3.99) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.17 (2.53 - 4.02) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.19 (2.55 - 4.03) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.21 (2.58 - 4.06) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.23 (2.59 - 4.05) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.24 (2.61 - 4.07) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.26 (2.61 - 4.11) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.28 (2.62 - 4.12) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.29 (2.62 - 4.14) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.31 (2.63 - 4.16) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.33 (2.64 - 4.19) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.35 (2.64 - 4.23) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.73 (2.16 - 3.42) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 1.42 (1.17 - 1.60) | 2019 | Modelled | Dugan et al., 2021 |
Number of people living with chronic HCV (RNA+/cAg)
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 264,473 (208,893 - 334,118) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 271,268 (215,197 - 342,252) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 278,459 (221,155 - 350,115) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 286,049 (228,207 - 359,677) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 294,043 (235,487 - 370,075) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 302,595 (242,961 - 381,319) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 311,493 (250,514 - 391,028) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 320,948 (257,738 - 402,144) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 330,797 (265,792 - 417,524) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 340,955 (272,439 - 430,068) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 351,495 (279,753 - 446,388) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 362,004 (289,895 - 458,096) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 372,666 (298,248 - 470,373) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 383,532 (306,550 - 483,957) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 394,775 (315,699 - 500,412) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 406,713 (324,140 - 515,867) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 419,072 (334,097 - 529,934) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 431,959 (344,309 - 545,514) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 445,326 (355,010 - 562,077) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 459,190 (366,119 - 581,775) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 473,606 (376,676 - 600,160) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 487,658 (389,731 - 618,977) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 501,389 (401,875 - 637,123) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 515,599 (412,178 - 654,393) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 531,323 (424,214 - 675,656) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 549,796 (438,035 - 695,452) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 571,321 (454,682 - 720,697) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 594,324 (473,461 - 751,515) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 617,288 (494,232 - 778,585) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 640,487 (507,767 - 802,449) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 635,075 (503,390 - 796,387) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 69,600 (57,100 - 78,100) | 2019 | Modelled | Dugan et al., 2021 |
HCV-related death rate
National
Download| Value (Deaths per 100,000) | Year | Type | Source |
|---|---|---|---|
| 1.01 (0.61 - 1.65) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 1.42 (0.88 - 2.18) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.39 (0.87 - 2.14) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.38 (0.86 - 2.11) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.37 (0.87 - 2.08) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.35 (0.86 - 2.04) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.34 (0.86 - 2.03) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.3 (0.83 - 1.92) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.3 (0.83 - 1.96) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.29 (0.82 - 1.90) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.28 (0.82 - 1.90) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.27 (0.80 - 1.89) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.24 (0.78 - 1.84) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.26 (0.81 - 1.85) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.23 (0.78 - 1.83) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.19 (0.75 - 1.77) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.19 (0.75 - 1.75) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.15 (0.73 - 1.72) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.12 (0.70 - 1.69) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.07 (0.65 - 1.65) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.01 (0.61 - 1.56) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.04 (0.63 - 1.60) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.98 (0.59 - 1.52) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.95 (0.57 - 1.47) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.94 (0.56 - 1.46) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.93 (0.56 - 1.47) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.92 (0.55 - 1.46) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.94 (0.56 - 1.49) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.96 (0.58 - 1.57) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 0.97 (0.60 - 1.59) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.01 (0.61 - 1.65) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HCV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 459 | 2016 | Modelled | WHO |
| 236 (142 - 383) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 236 (142 - 383) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 218 (134 - 355) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 206 (126 - 338) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 194 (117 - 309) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 183 (110 - 292) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 179 (107 - 282) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 173 (104 - 270) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 169 (101 - 261) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 168 (101 - 261) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 167 (100 - 257) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 165 (100 - 254) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 163 (99 - 251) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 164 (103 - 248) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 162 (103 - 243) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 162 (103 - 238) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 156 (98 - 232) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 155 (98 - 230) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 150 (95 - 224) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 147 (94 - 216) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 143 (91 - 213) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 139 (89 - 207) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 135 (86 - 199) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 131 (84 - 194) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 127 (81 - 191) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 126 (81 - 191) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 123 (78 - 186) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 121 (77 - 183) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 118 (73 - 180) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 115 (72 - 177) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 114 (70 - 175) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Modelled
HBV
1,688
2019
(1,060 - 2,511)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HBV chart
Modelled
HCV
236
2019
(142 - 383)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HCV chart
Prevalence < 5
HBV
3.44
(%)
2020, latest modelled
(2.63 - 4.50(%))
WHO
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines